respiratory
Infectious diseases

Azithromycin reduces rhinovirus replication in airways


Prophylactic treatment with azithromycin mitigates the impact of human rhinovirus infection in lung transplant recipients, Australian research shows. A WA study using large and small airway epithelial cells from five lung allograft recipients has confirmed rhinovirus caused significant cytotoxicity in both cell cultures. Viral infection at low titres in large airway epithelial cells significantly reduced cell ...

Already a member?

Enter your email to keep reading.


OR